CLINICAL_TRIALS
research
· 2026-03-20
Clinical Trial Update: HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation [Phase 1]
Summary
Phase 1 trial update evaluating bioequivalence of infant versus standard ivermectin formulations in healthy adults for scabies. The trial status is suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Murdoch Childrens Research Institute | Conditions: Scabies | Phase 1 | Status: SUSPENDED